Related Experiment Videos
Serotonin and treatment in obsessive-compulsive disorder
J S March1, L D Gutzman, J W Jefferson
1Department of Psychiatry, University of Wisconsin Hospital, Madison 53792.
Psychiatric Developments
|January 1, 1989
Summary
Obsessive-compulsive disorder (OCD) is linked to serotonin issues in the brain. This review explores the evidence for this connection and its impact on OCD treatment strategies.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Obsessive-compulsive disorder (OCD) has been recognized for centuries.
- Despite extensive study, OCD remains a complex challenge for mental health professionals.
- Recent research suggests a role for serotonergic neurotransmission dysfunction in OCD.
Purpose of the Study:
- To review the evidence supporting a serotonergic hypothesis for OCD.
- To discuss the implications of this hypothesis for OCD treatment.
Main Methods:
- Literature review of studies investigating serotonergic mechanisms in OCD.
- Analysis of clinical evidence linking serotonin to OCD pathophysiology.
- Examination of treatment outcomes related to serotonergic interventions.
Main Results:
- Evidence suggests that serotonergic neurotransmission is dysfunctional in individuals with OCD.
- Serotonin-related pathways are increasingly implicated in the neurobiology of OCD.
- Pharmacological and non-pharmacological interventions targeting the serotonin system show promise.
Conclusions:
- The serotonergic hypothesis provides a framework for understanding OCD.
- Dysfunctional serotonin pathways are a key area of focus for OCD treatment development.
- Targeting serotonergic neurotransmission is a critical strategy in managing OCD.